Position in BNTX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$306,991
+$23,486 QoQ
Shares Held
3,454
+16.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Marks Group Wealth Management, Inc holds $6,508,451 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
18,024 | $1,535,464 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
9,088 | $1,206,250 | |
| 3 | ASND |
Ascendis Pharma A/S
|
4,345 | $1,158,898 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,717 | $817,898 | |
| 5 | ERAS |
Erasca, Inc.
|
32,857 | $601,940 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
4,422 | $507,070 | |
| 7 | PCVX |
Vaxcyte, Inc.
|
7,224 | $419,931 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
15,000 | $261,000 |
All Filings in BNTX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $306,991 | 3,454 | Shares | Other | 2026-05-05 | |
| 2025-12-31 | $283,505 | 2,978 | Shares | Other | 2026-02-11 | |
| 2024-06-30 | $276,277 | 3,438 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $336,804 | 3,651 | Shares | Other | 2024-04-29 | |
| 2023-12-31 | $405,167 | 3,839 | Shares | Other | 2024-02-01 | |
| No filing history on record for this holder in this stock. | ||||||